Background illustration for clinical trials search

Paid Clinical Trials Newark

Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States

for
Crohn Disease, Ulcerative Colitis, IBD,
Location: New York NY, New Brunswick NJ, Chattanooga TN,
Sponsor: PredictImmune Ltd

Sex: All

Age: 16 - 70+

Code: NCT03952364

Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

for
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL),
Location: New York NY, New Brunswick NJ, New Haven CT,
Sponsor: Arvinas Inc.

Sex: All

Age: 18+

Code: NCT06393738

Phase1, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Brooklyn NY, New York NY, Florham Park NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase3, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: New York NY, The Bronx NY, Mineola NY, White Plains NY,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Brooklyn NY, New York NY, East Brunswick NJ, Mineola NY,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for
Cystic Fibrosis
Location: New York NY, Morristown NJ, New Hyde Park NY,
Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

for
Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis,
Location: New York NY, New Brunswick NJ, Rosedale NY,
Sponsor: Eidos Therapeutics, a BridgeBio company

Sex: All

Age: 18 - 70+

Code: NCT06563895

Phase3, Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

for
Stereotypical Prolonged Seizures
Location: New York NY, New Brunswick NJ, Philadelphia PA,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 12+

Code: NCT05077904

Phase3, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: New York NY, Manhattan NY, The Bronx NY,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase3, Recruiting

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

for
Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma
Location: Lake Success NY, New York NY, New Brunswick NJ,
Sponsor: Generate Biomedicines

Sex: All

Age: 18+

Code: NCT07484022

Phase1, Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: New York NY, The Bronx NY, Massapequa NY,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase3, Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: New York NY, Hackensack NJ, Mineola NY, Philadelphia PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase1, Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, Hackensack NJ, Boston MA, Buffalo NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase1, Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: New York NY, The Bronx NY, New Brunswick NJ,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: All

Age: 18+

Code: NCT01042379

Phase2, Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: New York NY, Hackensack NJ, The Bronx NY, Mineola NY,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase2, Phase3, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant
Location: New York NY, Morristown NJ, Philadelphia PA,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase3, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: New York NY, Long Island City NY, Hackensack NJ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase3, Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, Lake Success NY, East Brunswick NJ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Location: New York NY, New Brunswick NJ, Boston MA, Louisville KY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05685173

Phase1, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: New York NY, The Bronx NY, New Brunswick NJ,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase3, Recruiting